Deep Cholesterol Binding Sites on Mammalian Membrane Proteins
Ion Channels
[Letters refer to subunits as given in the PDB file, followed by the TM helix number; P Pore Helix; Units of E, kcals/mol with molar concentration units]
E | Donor | Acceptor | Local Residues (within 3 Å of a cholesterol –OH group) | |||||
Potassium Channels | ||||||||
Two-pore domain TWIK-1 human, 3ukm | ||||||||
-8.3 | Chl | OH | Thr225 [A P2] | OG1 | Ser224 [A P2] | Thr225 [A P2] | ||
-8.2 | Chl | OH | Thr225 [B P2] | OG1 | Thr117 [A P1] | Ser224 [B P2] | Thr225 [B P2] | |
-7.6 | Chl | OH | Leu115 [A P1] | O | Leu115 [A P1] | Ile142 [A2] | ||
Two-pore domain TRAAK in non-conductive down state, human, 3um7 | ||||||||
-8.4 | Chl | OH | Thr238 [B P2] | OG1 | Thr129 [A P1] | Thr237 [B P2] | Thr238 [B P2] | |
-8.1 | Chl | OH | Ser45 [B1] | OG | Tyr42 [B1] | Ser45 [B1] | Gly46 [B1] | |
-7.0 | Chl | OH | Thr212 [B3] | OG1 | Leu207 [B3] | Leu211 [B3] | Thr212 [B3] | |
-7.0 | Chl | OH | Leu151 [B2] | O | Leu151 [B2] | |||
-6.5 | Chl | OH | Leu208 [A3] | O | Leu208 [A3] | Pro213 [A3] | ||
Two-pore domain TRAAK in non-conductive down state in K+, human, 4wff | ||||||||
-6.6 | Chl | OH | Leu236 [A P2] | O | Leu236 [A P2] | |||
-6.6 | Chl | OH | Leu151 [A2] | O | Leu151 [A2] | |||
-6.4 | Chl | OH | Ile127 [B P1] | O | Ile127 [B P1] | Ile154 [B2] | Phe157 [B2] | Gly158 [B2] |
-6.4 | Chl | OH | Tyr42 [A1] | OH | Tyr42 [A1] | Phe148 [B2] | Tyr149 [B2] | |
Two-pore domain TRAAK in non-conductive down state in Tl+, human, 4wfh | ||||||||
-9.9 | Chl | OH | Ile127 [B P1] | O | Ile154 [B2] | Gly158 [B2] | ||
-8.5 | Chl | OH | Thr237 [A P2] | O | Thr237 [A P2] | Thr238 [A P2] | ||
Chl | OH | Thr238 [A P2] | OG1 | |||||
-8.3 | Chl | OH | Leu236 [A P2] | O | Leu236 [A P2] | Thr237 [A P2] | ||
-8 | Chl | OH | Leu151 [A2] | O | Leu151 [A2] | |||
-6.3 | Chl | OH | Tyr42 [A1] | OH | Tyr42 [A1] | Phe148 [B2] | Tyr149 [B2] | |
-5.9 | Chl | OH | Leu208 [B3] | O | Leu208 [B3] | Pro213 [B3] | Trp264 [B4] | |
Two-pore domain TRAAK in conductive up state in K+, human, 4wfe | ||||||||
6.5 | Chl | OH | Tyr42 [B1] | OH | Phe148 [A2] | Tyr149 [A2] | Tyr42 [B1] | |
-6.1 | Chl | OH | Tyr271 [A4] | OH | Cys206 [A3] | Tyr271 [A4] | ||
Tyr271 [A4] | OH | Chl | OH | |||||
Two-pore domain TRAAK in conductive up state in Tl+, human, 4wfg | ||||||||
-6.6 | Tyr42 [A1] | OH | Chl | OH | Tyr42 [A1] | Phe148 [B2] | Tyr149 [B2] | |
-6.3 | Chl | OH | Tyr42 [A1] | OH | Tyr42 [A1] | Phe148 [B2] | Tyr149 [B2] | |
Tyr42 [A1] | OH | Chl | OH | |||||
Two-pore domain TRAAK, domain-swapped, closed fenestrations, human, 4i9w | ||||||||
-6.8 | Chl | OH | Tyr42 [A1] | OH | Tyr42 [A1] | Phe148 [B2] | Tyr149 [B2] | |
Two-pore domain TREK-1 up state human, 4twk | ||||||||
-7.5 | Chl | OH | Tyr284 [A4] | OH | Ile215 [A3] | Tyr284 [A4] | ||
-6.1 | Chl | OH | Tyr57 [B1] | OH | Ile161 [A2] | Tyr162 [A2] | Leu165 [A2] | Tyr57 [B1] |
Two-pore domain TREK-1 up state mouse, 5vk5 | ||||||||
-6.2 | Chl | OH | Tyr57 [A1] | OH | Tyr57 [A1] | Ile161 [B2] | Tyr162 [B2] | |
-5.9 | Chl | OH | Leu221 [A3] | O | Leu221 [A3] | Pro226 [A1] | Trp277 [A4] | |
Two-pore domain TREK-1 up state mouse, 5vkn | ||||||||
-5.6 | Chl | OH | Tyr284 [A4] | OH | Cys219 [A3] | Tyr284 [A4] | ||
-5.5 | Chl | OH | Leu221 [A3] | O | Leu221 [A3] | Phe222 [A3] | ||
Two-pore domain TREK-1 complex with ML402, mouse, 5vkp | ||||||||
-5.6 | Chl | OH | Leu221 [A3] | O | Leu221 [A3] | Trp277 [A4] | ||
Two-pore domain TREK-2 up state human, 4bw5 | ||||||||
-6.6 | Chl | OH | Tyr87 [A1] | OH | Tyr87 [A1] | Leu191 [B2] | Tyr192 [B2] | Tyr87 [B1] |
Two-pore domain TREK-2 down state human (res. 3.8 A), 4xdj | ||||||||
-8.1 | Chl | OH | Thr281 [A P2] | OG1 | Thr280 [A P2] | Thr281 [A P2] | ||
-7.8 | Chl | OH | Ile194 [A2] | O | Ile194 [A2] | |||
-7.6 | Chl | OH | Leu279 [B P2] | O | Leu279 [B P2] | |||
Two-pore domain TREK-2 down state, Br-fluoxetine bound, human, 4xdl | ||||||||
-8.2 | Chl | OH | Ile194 [C2] | O | Ile194 [C2] | |||
-8.2 | Chl | OH | Thr281 [D P2] | OG1 | Thr280 [D P2] | Thr281 [D P2] | ||
Two-pore domain TREK-2 down state, norfluoxetine bound (res 3.6 Å), human, 4xdk | ||||||||
-8.4 | Chl | OH | Ile170 [A P1] | O | Ile197 [A2] | Gly201 [A2] | ||
-8.2 | Chl | OH | Leu279 [B P2] | O | Leu279 [B P2] | Thr280 [B P2] | Thr281 [B P2] | |
Voltage-gated channel Kv1.2, rat, 3lut | ||||||||
None | ||||||||
Voltage-gated channel Kv1.2, rat, 2a79 | ||||||||
-8.0 | Chl | OH | Thr401 [A6] | OG1 | Phe334 [A5] | Thr401 [A6] | ||
-7.9 | Chl | OH | Thr401 [A6] | OG1 | Ala397 [A5] | Thr401 [A6] | ||
Voltage-gated channel Kv1.2/Kv2.1 paddle chimera [PDB numbering changed to match 2a79], rat, 2r9r | ||||||||
-6.3 | Chl | OH | Thr401 [A6] | OG1 | Phe334 [A5] | Gly338 [A5] | Thr401 [A6] | |
Voltage-gated channel Kv1.2/Kv2.1 paddle chimera [PDB numbering changed to match 2a79] rat, 3lnm | ||||||||
-7.8 | Chl | OH | Thr401 [A6] | OG1 | Phe334 [A5] | Gly338 [A5] | Met372 [A P] | Thr401 [A6] |
Voltage-gated channel Kv1.2/Kv2.1 paddle chimera, inactivated V410W mutant, rat, 5wie | ||||||||
None | ||||||||
Inward-rectifier Kir 2.2 chicken, 3jyc | ||||||||
-6.7 | Trp94 [A1] | NE1 | Chl | O | Trp94 [A1] | Gln141 [A P] | ||
Inward-rectifier Kir 2.2 mutant apo form, 3spj | ||||||||
-9.1 | Chl | OH | Gln141 [A P] | O | Gln141 [A P] | Ser166 [A2] | Gly169 [A2] | Cys170 [A2] |
-7.7 | Trp94 [A1] | NE1 | Chl | O | Phe90 [A1] | Trp94 [A1] | Gln141 [A P] | |
Inward-rectifier Kir 2.2 in complex with PIP2 chicken, 3spi | ||||||||
-7.0 | Chl | OH | Gln141 [A P] | O | Gln141 [A P] | Ser166 [A2] | Gly169 [A2] | Cys170 [A2] |
Inward-rectifier Kir 2.2 mutant in complex with PIP2 chicken, 3spg | ||||||||
None | ||||||||
Inward-rectifier Kir 2.2 mutant in complex with PIP2 chicken, 3sph | ||||||||
None | ||||||||
Inward-rectifier Kir 2.2 in complex with PPA chicken, 3spc | ||||||||
None | ||||||||
Inward-rectifier Kir 2.2 K62W mutant chicken, 5kuk | ||||||||
None | ||||||||
G-protein gated channel, GIRK2 (Kir 3.2) wild type. mouse, 3syo | ||||||||
-7.0 | Chl | OH | Ser181 [A2] | OG | Ser177 [A2] | Gly180 [A2] | Ser181 [A2] | |
G-protein gated channel, GIRK2 (Kir 3.2) D228N mutant. mouse, 3syc | ||||||||
-6.1 | Chl | OH | Tyr102 [A1] | OH | Tyr102 [A1] | |||
Tyr102 [A1] | OH | Chl | OH | |||||
-6.0 | Chl | OH | Glu152 [B P] | OE2 | Tyr102 [B1] | Glu152 [B P] | ||
Tyr102 [B1] | OH | Chl | OH | |||||
G-protein gated channel, GIRK2 (Kir 3.2) wild type plus PIP2, mouse, 3sya | ||||||||
-7.2 | Chl | OH | Ser181 [A2] | OG | Ser177 [A2] | Ser181 [A2] | Tyr102 [D1] | |
G-protein gated channel, GIRK2 (Kir 3.2) R201A mutant plus PIP2, mouse, 3syq | ||||||||
-9.1 | Chl | OH | Ser181 [C2] | OG | Ser177 [C2] | Ser181 [C2] | ||
-9.1 | Chl | OH | Glu152 [B P] | O | Glu152 [B P] | Gly180 [B2] | ||
Chl | OH | Gly180 [B2] | O | |||||
-7.9 | Chl | OH | Ser177 [B2] | O | Ser177 [B2] | Gly180 [B2] | Ser181 [B2] | |
Chl | OH | Ser181 [B2] | OG | |||||
-7.5 | Chl | OH | Tyr102 [D1] | OH | Tyr102 [D1] | Asn184 [D2] | ||
Tyr102 [D1] | OH | Chl | OH | |||||
G-protein gated channel, GIRK2 (Kir 3.2) plus G-protein subunits. mouse, 4kfm | ||||||||
-9.6 | Chl | OH | Ser181 [F2] | OG | Ser177 [F2] | Ser181 [F2] | ||
-8.9 | Chl | OH | Glu152 [J P] | O | Glu152 [J P] | Gly180 [J2] | ||
Chl | OH | Glu152 [J P] | OE2 | |||||
-8.5 | Chl | OH | Ser181 [A2] | OG | Ser181 [A2] | Asn184 [J2] | ||
Calcium-activated channel Slo1 (BK) sea slug, 5tj6 | ||||||||
-7.5 | Chl | OH | Ser29 [A1] | OG | Thr26 [A1] | Ser29 [A1] | Gly30 [A1] | |
Lysosomal K+-selective channel TMEM175 homolog, marine worm, 5vre | ||||||||
None | ||||||||
Calcium-ion selective Channels | ||||||||
Orai calcium release-activated CRAC channel, Drosophila, 4hkr | ||||||||
-6.8 | Chl | OH | Thr283 [A4] | O | Thr283 [A4] | Leu286 [A4] | Ile287 [A4] | |
Orai calcium release-activated CRAC channel mutant, Drosophila, 4hks | ||||||||
-6.6 | Chl | OH | Thr283 [A4] | O | Thr283 [A4] | Leu286 [A4] | Ile287 [A4] | |
Transient Receptor Potential (TRP) Channels | ||||||||
TRPM4 cation channel, apo state, human, 6bcj | ||||||||
None | ||||||||
TRPM4 cation channel, apo state, human, 6bcl | ||||||||
None | ||||||||
TRPM4 cation channel, ATP bound, human, 6bco | ||||||||
None | ||||||||
TRPM4 cation channel, ATP bound, human, 6bcq | ||||||||
None | ||||||||
TRPM4 cation channel, Ca-free, human, 6bqr | ||||||||
None | ||||||||
TRPM4 cation channel, Ca-bound, human, 6bqv | ||||||||
None | ||||||||
TRPML1, human, 5wj9 | ||||||||
-7.8 | Chl | OH | Tyr439 [A5] | OH | Tyr439 [A5] | Ser500 [A6] | ||
-6.9 | Chl | OH | Ser503 [A6] | OG | Tyr499 [A6] | Ser503 [A6] | ||
TRPML3, marmoset, 5w3s | ||||||||
-7.1 | Chl | OH | Tyr491 [A6] | OH | Tyr491 [A6] | Ile455 [D P] | ||
Tyr491 [A6] | OH | Chl | OH | |||||
TRPV1 rat, 3j5p | ||||||||
-7.7 | Chl | OH | Thr550 [A4] | OG1 | Met547 [A4] | Thr550 [A4] | Asn551 [A4] | |
-7.5 | Chl | OH | Ser483 [A2] | OG | Ser483 [A2] | Gly484 [A2] | ||
Ser483 [A2] | OG | Chl | OH | |||||
TRPV1 rat, 5irz | ||||||||
-8.2 | Chl | OH | Ser483 [A2] | OG | Ser483 [A2] | Gly484 [A2] | ||
Ser483 [A2] | OG | Chl | OH | |||||
-8.0 | Chl | OH | Thr550 [A4] | OG1 | Ala546 [A4] | Met547 [A4] | Thr550 [A4] | |
TRPV1 complex with DkTx and RTX, rat, 5irx | ||||||||
-8.6 | Chl | OH | Thr550 [A4] | OG1 | Ala546 [A4] | Met547 [A4] | Thr550 [A4] | |
-6.9 | Chl | OH | Ser483 [A2] | OG | Ser483 [A2] | Gly484 [A2] | ||
Ser483 [A2] | OG | Chl | OH | Ser483 [A2] | Gly484 [A2] | |||
TRPV1 complex with capsaicin, rat, 5is0 | ||||||||
-8.7 | Chl | OH | Thr550 [A4] | OG1 | Ala546 [A4] | Met547 [A4] | Thr550 [A4] | |
-6.6 | Chl | OH | Ser483 [A2] | OG | Ile479 [A2] | Val482 [A2] | Ser483 [A2] | |
TRPV6 rat, 5iwk | ||||||||
None | ||||||||
TRPV6 rat, 5wo6 | ||||||||
-5.8 | Chl | OH | Thr430 [A3] | OG1 | Val426 [A3] | Ile427 [A3] | Thr430 [A3] | |
TRPV6 rat, 5wo7 | ||||||||
-6.3 | Chl | OH | Val498 [A5] | O | Val498 [A5] | Val499 [A5] | Gly502 [A5] | |
TRPV6-Del1, rat, 5wo8 | ||||||||
-6.1 | Chl | OH | Thr430 [A3] | OG1 | Val426 [A3] | Ile427 [A3] | Thr430 [A3] | |
TRPV6, plus Ca2+, rat, 5wo9 | ||||||||
-7.1 | Chl | OH | Cys462 [A4] | O | Trp461 [A4] | Cys462 [A4] | Val464 [A4] | Met465 [A4] |
Met465 [A4] | N | Chl | OH | |||||
PKD2 polycystic kidney disease channel, human, 5t4d | ||||||||
-6.7 | Chl | OH | Thr663 [A6] | OG1 | Tyr611 [A5] | Thr663 [A6] | ||
Tyr611 [A5] | OH | Chl | OH | |||||
Glutamate Receptors | ||||||||
GluA2 glutamate receptor (AMPA) apo form A, rat, 4u2p | ||||||||
-9.1 | Tyr533 [A1] | OH | Chl | OH | Tyr533 [A1] | Arg599 [D2] | ||
-8.2 | Chl | OH | Thr609 [A2] | OG1 | Trp605 [A2] | Thr609 [A2] | ||
-7.3 | Chl | OH | Thr609 [A2] | OG1 | Trp605 [A2] | Thr609 [A2] | ||
Trp605 [A2] | NE1 | Chl | OH | |||||
GluA2 glutamate receptor (AMPA) with kainate crystal form A, rat, 4u1w | ||||||||
-7.8 | Chl | OH | Thr609 [A2] | OG1 | Trp605 [A2] | Thr609 [A2] | ||
-7.5 | Trp605 [A2] | NE1 | Chl | OH | Trp605 [A2] | Thr609 [A2] | ||
GluA2 glutamate receptor (AMPA) with kainate crystal form B, rat, 4u1x | ||||||||
-7.6 | Chl | OH | Thr609 [A2] | OG1 | Thr609 [A2] | |||
-6.8 | Chl | OH | Thr609 [A2] | OG1 | Thr609 [A2] | Trp606 [D2] | ||
GluA2 glutamate receptor (AMPA) mutant with toxin etc, rat, 4u5b | ||||||||
-9.2 | Tyr533 [C1] | OH | Chl | OH | Arg599 [B2] | Tyr533 [C1] | ||
-8.3 | Chl | OH | Thr609 [A2] | OG1 | Trp605 [A2] | Thr609 [A2] | ||
Trp605 [A2] | NE1 | Chl | OH | |||||
-7.7 | Trp605 [A2] | NE1 | Chl | OH | Trp605 [A2] | |||
P2X channels | ||||||||
ATP-gated P2X3 channel closed apo state, human, 5svj | ||||||||
-6.9 | Chl | OH | Thr336 [A2] | OG1 | Gly333 [A2] | Thr336 [A2] | ||
ATP-gated P2X3 channel ATP bound open state, human, 5svk | ||||||||
-7.7 | Chl | OH | Ser331[A2] | OG | Thr330 [A2] | Ser331 [A2] | ||
Chl | OH | Thr330 [A2] | OG1 | |||||
Chl | OH | Thr330 [A2] | O | |||||
-6.2 | Chl | OH | Ser36 [A1] | OG1 | Leu33 [A1] | Ser36 [A1] | Tyr37 [A1] | |
ATP-gated P2X3 channel ATP-bound, desensitized state, human, 5svl | ||||||||
-8.9 | Chl | OH | Thr330 [A2] | OG1 | Thr330 [A2] | Ser331 [A2] | ||
-8.9 | Chl | OH | Ser331 [A2] | OG | Thr330 [A2] | Ser331 [A2] | ||
ATP-gated P2X3 channel agonist bound desensitized state, human, 5svm | ||||||||
-11.4 | Chl | OH | Ser331 [A2] | OG | Ala327 [A2] | Thr330 [A2] | Ser331 [A2] | |
Chl | OH | Thr330 [A2] | OG1 | |||||
ATP-gated P2X3 channel agonist bound desensitized state, human, 5svp | ||||||||
-11.4 | Chl | OH | Ser331 [A2] | OG | Ala327 [A2] | Thr330 [A2] | Ser331 [A2] | |
Chl | OH | Thr330 [A2] | OG1 | |||||
ATP-gated P2X3 channel competitive antagonist bound closed state, human, 5svq | ||||||||
None | ||||||||
ATP-gated P2X3 channel competitive antagonist bound closed state, human, 5svr | ||||||||
-6.6 | Chl | OH | Ser36 [A1] | OG | Ser36 [A1] | |||
-6.3 | Chl | OH | Thr336 [A2] | OG1 | Val332 [A2] | Gly333 [A2] | Thr336 [A2] | |
ATP-gated P2X4 channel apo state, zebra fish, 3h9v | ||||||||
None | ||||||||
ATP-gated P2X4 channel apo closed state, zebra fish, 3i5d | ||||||||
None | ||||||||
ATP-gated P2X4 channel plus CTP open state, zebra fish, 5wzy | ||||||||
-6.9 | Chl | OH | Ala344 [A2] | O | Ala344 [A2] | Ala347 [A2] | Leu348 [A2] | |
ATP-gated P2X4 channel ATP bound open state, zebra fish, 4dw1 | ||||||||
-7.3 | Chl | OH | Gly343 [A2] | O | Gly343 [A2] | Ala344 [A2] | ||
ATP-gated P2X4 channel ATP-free closed state, zebra fish, 4dw0 | ||||||||
None | ||||||||
ATP-gated P2X4 channel ATP bound open state, Gulf Coast tick, 5f1c | ||||||||
None | ||||||||
ATP-gated P2X7 channel plus competitive antagonist, chicken, 5xw6 | ||||||||
-8.4 | Chl | OH | Ser326 [B2] | OG | Thr322 [B2] | Ser326 [B2] | ||
-6.6 | Chl | OH | Tyr330 [C2] | OH | Tyr330 [C2] | |||
-6.5 | Chl | OH | Thr327 [C2] | OG1 | Thr327 [C2] | Ile328 [C2] | ||
Thr327 [C2] | OG1 | Chl | OH | |||||
Acid-sensing ion-channel (ASIC), chicken, 4nyk | ||||||||
None | ||||||||
Chloride channels | ||||||||
Bestrophin-1 (BEST1) Ca-activated Cl channel, jungle fowl, 4rdq | ||||||||
-9.5 | Chl | OH | Ala73 [A2] | O | Asn70 [A2] | Ser71 [A2] | Ala73 [A2] | Glu74 [A2] |
Bestrophin-1 (BEST1) Ca-activated Cl channel mutant, jungle fowl, 5t5n | ||||||||
-8.9 | Chl | OH | Ala73 [A2] | O | Asn70 [A2] | Ala73 [A2] | Arg255 [A3] | |
Neurotransmitter-gated ion channels of the Cys-loop receptor family | ||||||||
Glycine receptor complex with strychnine, human, 5cfb | ||||||||
-7.2 | Chl | OH | Ser296 [A3] | OG | Leu292 [A3] | Ser296 [A3] | ||
Glycine receptor complex with AM-3607, human, 5tio | ||||||||
-7.5 | Chl | OH | Ser296 [A3] | OG | Leu292 [A3] | Ser296 [A3] | ||
Glycine receptor, mutant, complex with AM-3607, human, 5tin | ||||||||
-8.3 | Chl | OH | Ser296 [A3] | OG | Leu292 [A3] | Phe293 [A3] | Ser296 [A3] | |
Glycine receptor, complex with Gly and ivermectin, human, 5vdh | ||||||||
-8.0 | Chl | OH | Ser296 [A3] | OG | Leu292 [A3] | Phe293 [A3] | Ser296 [A3] | |
GABA-A receptor (β3 homopentamer), human, 4cof | ||||||||
-7.5 | Chl | OH | Ser436 [A4] | OG | Pro432 [A4] | Phe435 [A4] | Ser436 [A4] | |
GABA-A receptor (α5 TMD - β3 ECD chimera) with pregnanolone, human, 5o8f | ||||||||
-8.1 | Chl | OH | Ser302 [A3] | OG | Ala298 [A3] | Ser302 [A3] | ||
Ser302 [A3] | OG | Chl | OH | |||||
-7.5 | Chl | OH | Thr408 [A4] | OG1 | Leu405 [A4] | Thr408 [A4] | Phe409 [A4] | |
Serotonin 5-HT3 receptor, mouse, 4pir | ||||||||
-7.6 | Chl | OH | Thr445 [A4] | OG1 | Ala441 [A4] | Tyr442 [A4] | Thr445 [A4] |